D
Bloomios, Inc.
BLMS
OTC PK
$2.50 -$0.24-8.76% Volume200 08/05/2022 12:24PM Eastern Quotes delayed
Recommendation
Prev Close
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 5/16/2022Upgraded
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 5/16/2022 due to a noticeable increase in the growth index.
E
Sell 5/13/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 5/13/2022 due to a decline in the valuation index.
D
Sell 5/4/2022Upgraded
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 05/04/2022.
E
Sell 5/1/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell 4/21/2022Upgraded
Bloomios, Inc. (BLMS) was upgraded to D from E+ on 04/21/2022.
E
Sell 4/20/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, efficiency index and solvency index. Net income declined 95.44% from -$296.2 to -$578.9, debt to equity increased from -2.55 to -1.57, and total capital declined 37.87% from $1.6M to $994.6.
D
Sell 2/24/2022Downgrade
Bloomios, Inc. (BLMS) was downgraded to D from D+ on 2/24/2022 due to a large decline in the total return index and volatility index.
D
Sell 12/29/2021Upgraded
Bloomios, Inc. (BLMS) was upgraded to D+ from D on 12/29/2021 due to a noticeable increase in the total return index, solvency index and growth index.
D
Sell 5/18/2021Upgraded
XLR Medical Corp. (XLRM) was upgraded to D from E+ on 5/18/2021 due to a large increase in the total return index, efficiency index and valuation index.
E
Sell 3/6/2020Upgraded
XLR Medical Corp. (XLRM) was upgraded to E+ from E- on 3/6/2020 due to an increase in the total return index and growth index. Earnings per share increased from -$0.0001 to $0, EBIT increased 40% from -$1 to -$600, and operating cash flow increased 20% from -$1 to -$800.
E
Sell 10/21/2019Upgraded
XLR Medical Corp. (XLRM) was upgraded to E- from on 10/21/2019 due to a significant increase in the solvency index, efficiency index and total return index. Net income increased 83.05% from -$5.9 to -$1, and total capital increased 33.33% from -$300 to -$200.
Weiss Ratings